Skip to main content

Table 2 Univariable and multivariable analyses for each clinical feature

From: A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation

Clinical feature

Number

Univariate Analysis

Multivariate Analysis

HR

95% CI

P value

HR

95% CI

P value

Risk Parameter(high-risk/low-risk)

427/419

2.926

1.748–4.898

<0.001

2.917

1.724–4.935

<0.001

Age(<65/≥65)

626/241

2.270

1.568–3.287

<0.001

2.619

1.800–3.811

<0.001

Stage(I-II/III-IV)

659/208

2.478

1.719–3.572

<0.001

2.023

1.155–3.542

0.014

T(I-II/III-IV)

741/126

1.667

1.099–2.530

0.016

0.788

0.466–1.333

0.374

N(0/1–3)

421/446

2.235

1.521–3.285

<0.001

1.570

0.983–2.505

0.059

M(0/1–3)

851/16

6.121

3.361–11.151

<0.001

3.473

1.799–6.706

<0.001

  1. Abbreviations: T,Tumor;N,Lymph Node;M,Metastasis; HR, hazard ratio; CI, confidential interval